Trial Profile
A randomized controlled study comparing lubiprostone and magnesium oxide for treatment of chronic constipation in patients with Parkinson disease. -to evaluation by change of intestinal bacterial flora-
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 05 Apr 2017
Price :
$35
*
At a glance
- Drugs Lubiprostone (Primary) ; Magnesium oxide
- Indications Constipation
- Focus Therapeutic Use
- 21 Mar 2017 New trial record